Concepedia

Steven Hubert

SH

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2016

Affiliations

Synthetic Biologics (United States)(Current)

Steven Hubert is an author at Synthetic Biologics (United States) specializing in clinical microbiology, antibiotics, and antimicrobial resistance.

Top concepts

MedicineAntibioticsMicrobiologyInfection ControlClinical MicrobiologyAntimicrobial ResistanceHealthMicrobiomePharmacologyGut Microbiome

Publications per year

2016–2017

4

Publications

4

Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection

Michael Kaleko, J. Andrew Bristol, Steven Hubert et al. · Anaerobe · 2016 · 68 citations · Full text

Dysbiosis, Antibiotic-mediated Damage, Complex Ecosystem +16

Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies

Tracey Roberts, John F. Kokai‐Kun, Olivia Coughlin et al. · Clinical Drug Investigation · 2016 · 30 citations

Antimicrobial Susceptibility, Antimicrobial Stewardship, Antibiotics +12

Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation

Steven Hubert, A. V. Chadwick, Vince Wacher et al. · Journal of Pharmaceutical Sciences · 2017 · 26 citations · Full text

Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon

Andrew Bristol, Steven Hubert, Felix Hofmann et al. · International Journal of Pharmaceutics · 2017 · 13 citations · Full text

1–4 of 4